Cited by 908Wound Healing and TreatmentsProtease and Inhibitor MechanismsPineapple and bromelain studies

Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors

Trengove, Naomi J., Stacey, Michael C., Macauley, Shawn, Bennett, Neil, Gibson, Jane, Burslem, Frank, Murphy, Gillian, Schultz, Gregory·1999·Wound Repair and Regeneration

Abstract

To assess the differences in proteolytic activity of acute and chronic wound environments, wound fluids were collected from acute surgical wounds (22 samples) and chronic wounds (25 samples) of various etiologies, including mixed vessel disease ulcers, decubiti and diabetic foot ulcers. Matrix metalloproteinase (MMP) activity measured using the Azocoll assay was significantly elevated by 30 fold in chronic wounds (median 22.8 microg MMP Eq/ml) compared to acute wounds (median 0.76 microg MMP Eq/ml) (p < 0.001). The addition of the matrix metalloproteinase inhibitor Illomostat decreased the matrix metalloproteinase activity by approximately 90% in all samples, confirming that the majority of the activity measured was due to matrix metalloproteinases. Gelatin zymograms indicated predominantly elevated matrix metalloproteinase-9 with smaller elevations of matrix metalloproteinase-2. In addition tissue inhibitor of metalloproteinase-1 levels were analyzed in a small subset of acute and chronic wounds. When tissue inhibitor of metalloproteinase-1 levels were compared to protease levels there was an inverse correlation (p = 0.02, r = - 0.78). In vitro degradation of epidermal growth factor was measured by addition of 125I labelled epidermal growth factor to acute and chronic wound fluid samples. There was significantly higher degradation of epidermal growth factor in chronic wound fluid samples (mean 28.1%) compared to acute samples (mean 0.6%). This also correlated to the epidermal growth factor activity of these wound fluid samples (p < 0. 001, r = 0.64). Additionally, the levels of proteases were assayed in wound fluid collected from 15 venous leg ulcers during a nonhealing and healing phase using a unique model of chronic wound healing in humans. Patients with nonhealing venous leg ulcers were admitted to the hospital for bed rest and wound fluid samples were collected on admission (nonhealing phase) and after 2 weeks (healing phase) when the ulcers had begun to heal as evidenced by a reduction in size (median 12%). These data showed that the elevated levels of matrix metalloproteinase activity decreased significantly as healing occurs in chronic leg ulcers (p < 0.01). This parallels the processes observed in normally healing acute wounds. This data also supports the case for the addition of protease inhibitors in chronic wounds in conjunction with any treatments using growth factors.

Integrity signals

Registry

Crossref · 10.1046/j.1524-475x.1999.00442.x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Trengove, N. J., Stacey, M. C., Macauley, S., Bennett, N., Gibson, J., Burslem, F., Murphy, G., & Schultz, G.
Affiliations
The University of Western Australia (AU)
Venue
Wound Repair and Regeneration
Publisher
Wiley
Published
1999-11
Volume
7
Issue
6
Pages
442-452
ISSN
  • 1067-1927 (ISSN-L)
  • 1524-475X
OpenAlex
W1980923037
Cited by
908
References
40
Citations by year
2026: 24 · 2025: 27 · 2024: 23 · 2023: 22 · 2022: 27 · 2021: 38 · 2020: 30 · 2019: 36 · 2018: 43 · 2017: 32 · 2016: 46 · 2015: 36 · 2014: 55 · 2013: 60 · 2012: 50
FWCI
11.68
Type
journal article
Language
en
Open access
closed
Locations
  • Wound Repair and Regeneration (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
Keywords
chronic wounds, acute wounds, matrix metalloproteinases, MMP-9, MMP-2, TIMP-1, protease inhibitors, wound fluid, venous leg ulcers, diabetic foot ulcer, pressure ulcers, wound healing, proteolytic activity
MeSH terms
Acute Disease, Adult, Aged, Aged, 80 and over, Chronic Disease, Pressure Ulcer, Enzyme-Linked Immunosorbent Assay, Female, Humans, Leg Ulcer, Male, Mastectomy, Middle Aged, Endopeptidases, Wound Healing, Cytokines, Diabetic Foot, Statistics, Nonparametric, Leukocyte Elastase, Tissue Inhibitor of Metalloproteinases, Matrix Metalloproteinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review